Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check2 days agoChange DetectedA notice about NIH’s website transition and terminology appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedA 403 Forbidden page is now shown, with a basic header and Home link, replacing the prior detailed study content and documents with an access-restricted screen.SummaryDifference18%

- Check37 days agoChange DetectedThe page displays a new revision tag: Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates the page has been updated to reflect a newer version.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision label was updated to v3.6.6, signaling a new build of the page. This change does not alter the study information or user-visible content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This indicates a minor maintenance update that does not alter the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.